Magnetic aerosol drug targeting in lung cancer therapy using permanent magnet
Mohammad K. D. Manshadi, Mahsa Saadat, Mehdi Mohammadi, Reza Kamali, Milad Shamsi, Mozhgan Naseh, Amir Sanati-Nezhad Figure S1 . Schematic view of magnetic aerosol drug targeting (MADT) for lung cancer therapy. Table S1 . The development stages of lung cancer SCLC Limited disease: Disease confined to one hemithorax and can be adequately encompassed by a radiation therapy port (Sekine et al., 2016) Extensive stage: Cancer has proliferated to other regions of the body (Dean and Kreis, 2018) NSCLC (Alfonse et al., 2014) Occult carcinoma: Tumor presence is proven by cancer cells detected in sputum. The tumor is not visualized. Stage 0 (Carcinoma in situ): The tumor is small and has not spread into the lung.
Stage 1
A: 3 cm or less across the tumor which does not spread in the lymph nodes. B: Tumor spreads into the underlying lung tissues but does not affect the lymph nodes.
Stage 2
A: 3 cm or less across the tumor which spreads in nearest lymph nodes. B: Several tumors exist and at least one is larger than 5 cm across, or at least one tumor has spread into one of the main blood vessels.
Stage 3
A: Tumor spreads in the nearest lymph nodes, or at least one tumor has spread into one of the main blood vessels. B: Tumor spreads to the larger area of the lung, or lung cancer cell spread into fluid around the lung. (Pourmehran et al., 2015) 2-6 µm Doxorubicin Non-uniform magnetic field used in G0-G2 lung model 12% 100%
Pourmehran et al. (Pourmehran et al., 2016) 2-6 µm Doxorubicin
Non-uniform magnetic field used in oral cavity, larynx, pharynx and trachea along with six generations of human lung 15% 100%
Ostrovski et al. (Ostrovski et al., 2016) 0.5-3 µm SPION Permanent magnet was used on anatomically inspired, space-flling, multigeneration acinar airway tree ROI 40% 100%
Kenjeres and Tjin (Kenjereš and Tjin, 2017) 0.1-10 µm iron oxidemaghemite core Magnetic deposition on trachea and last generations in a model from mouth inlet to the eighth generation of the bronchial bifurcations 23% 85% Russo et al. (Russo et al., 2017) 5 nm gold/iron-oxide A coil magnetic source was used in a model of trachea, with its primary and secondary bronchi with target on ROI 50% 47% SPION: superparamagnetic iron oxide nanoparticles, ROI: region of interest, N.A: not available, CA: cromoglycic acid, NIM: Nano-in-microparticle Figure S2 . The effect of magnet angle respect to the branches on particle retention efficacy.
A) Schematic illustration of the inclined magnet, B)
The PDF values at different magnet's angles, C) Magnetic flux density for the magnet placed at ϴ=30 respect to the branch, D) Magnetic flux density for the magnet placed at ϴ=90 respect to the branch.
